Scilex Holding (SCLX) Change in Receivables (2022 - 2026)

Scilex Holding (SCLX) posted quarterly Change in Receivables of -$4.6 million for Q1 2026, up 70.95% year-over-year from -$2.7 million in Q1 2025, and down 792.32% on a QoQ basis from $664000.0 in Q4 2025.

Scilex Holding (SCLX) Change in Receivables (2022 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Change in Receivables for 5 consecutive years, with -$4.6 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Change in Receivables rose 70.95% year-over-year to -$4.6 million; the TTM figure through Mar 2026 stood at -$2.6 million (up 44.15% YoY), while the FY2025 annual figure was -$13.8 million, down 320.79% from the prior year.
  • Change in Receivables came in at -$4.6 million for Q1 2026 at Scilex Holding, down from $664000.0 in the prior quarter.
  • The five-year high for Change in Receivables was $18.2 million in Q4 2023, with the low at -$15.8 million in Q1 2025.
  • Average Change in Receivables over 5 years is $480117.6, with a median of $664000.0 recorded in 2025.
  • The largest YoY upside for Change in Receivables was 1605.74% in 2023 against a maximum downside of 807.75% in 2023.
  • Year by year, Change in Receivables stood at $3.8 million in 2022, then surged by 382.96% to $18.2 million in 2023, then plunged by 55.43% to $8.1 million in 2024, then plunged by 91.8% to $664000.0 in 2025, then tumbled by 792.32% to -$4.6 million in 2026.
  • According to Business Quant data, Change in Receivables over the past three periods registered -$4.6 million, $664000.0, and -$4.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 595.00 Mn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -87.00 Mn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -413.00 Mn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -134.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn -4.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.60 Mn
Mar 31, 2026 -4.60 Mn
Dec 31, 2025 664,000.00
Dec 31, 2025 664,000.00
Sep 30, 2025 -4.83 Mn
Sep 30, 2025 -4.83 Mn
Jun 30, 2025 6.15 Mn
Jun 30, 2025 6.15 Mn
Mar 31, 2025 -15.82 Mn
Mar 31, 2025 -15.82 Mn
Dec 31, 2024 8.10 Mn
Dec 31, 2024 8.10 Mn
Sep 30, 2024 -5.24 Mn
Sep 30, 2024 -5.24 Mn
Jun 30, 2024 8.29 Mn
Jun 30, 2024 8.29 Mn
Mar 31, 2024 -4.88 Mn
Mar 31, 2024 -4.88 Mn
Dec 31, 2023 18.17 Mn
Dec 31, 2023 18.17 Mn